From Genomic Precision Medicine to Functional Precision Medicine in Hematology

We all know that even if several patients have the same diagnosis, they may not respond the same way to the same therapy. During the EHA Congress, Sigrid Skånland, Institute for Cancer Research in Oslo, presented a general lecture on the status of precision hematology. As you can hear in this MEDtalk, Sigrid Skånland explained why genomic precision medicine is not enough and why drug sensitivity screening of the patient’s cells can be a step forward in future treatment.